Press release
Contract Research Oganization Market Projections 2027 | IQVIA, Pharmaceutical Product Development and PRA Health Science, PAREXEL
To highlight, numerous pharma and biopharmaceutical companies have started outsourcing clinical trial services, boosting industry growth. In addition, several CRO companies are focusing on expansion strategies such as mergers, acquisitions, as well as product launch initiatives.
Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/3012
For instance, in December 2020, a leading provider of alternative investment products, Investcorp, announced the acquisition of Sanos Group, which is a leading provider of specialized clinical trial services to the worldwide biotechnology and pharmaceutical industry.
Similar initiatives are expected to drive the demand for contract research organization services through the forthcoming years. On this note, the contract research organization (CRO) market share is anticipated to surpass USD 74.2 billion by 2027, states the latest research by Global Market Insights, Inc.
This growth is due to an escalation in the outsourcing of research activities to academic institutions. Academic institutes are expected to depict a remarkable CAGR of 6.2% through the projected span. Several academic medical institutes have core IRB (Institutional Review Boards) that are responsible for supervising the moral manner of medical research. These boards also provide sites as well as large urban areas having a greater pool of medical participants.
The contract research organization (CRO) market is further driven by an increase in investments in research and development activities in the areas of gastroenterology & hepatology. The segment is set to record a value of USD 3 billion of the overall market share by 2027.
This revenue is attributed to the rising focus of various types of contract research organizations on clinical trial development in the sector of gastroenterology & hepatology. Increasing incidences of chronic hepatology disorders comprising cirrhosis and hepatitis-A at the global level are expected to augment the new drug development process for the treatment of these disorders, bolstering contract research organization (CRO) industry outlook through the forecasted period.
Speaking of which, there is a considerable rise in number of clinical trials as well as R&D initiatives, emergence of severe diseases, and a huge patient pool in Asia Pacific. In fact, the regional contract research organization market size is estimated to grow at a substantial CAGR of 9.1% between 2021 and 2027.
In addition, governments of numerous countries in the Asia Pacific are showing a keen interest in the provision of funding for drug discovery and associated research studies. Further, the region has also recorded a remarkable shift in biotechnology firms, which has been instrumental in impelling the growth of contract research organization (CRO) industry.
Market, By Therapeutic Area
• Oncology
• Clinical pharmacology
• Cardiology
• Infectious disease
• Neurology
• Gastroenterology & Hepatology
• Ophthalmology
• Others
Market, By End-use
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes
Request for customization @ https://www.gminsights.com/roc/3012
To add on, amid the COVID-19 pandemic, a spike in the number of SARS-CoV-2 cases has been responsible for attracting CROs for conducting trials to fast-track procedures and take advantage of the huge patient population, thereby propelling Asia Pacific CRO market growth through 2027.
In a nutshell, an increase in the expenditure on research and development activities and a rise in the number of drugs in numerous phases will spur contract research organization market size through the assessment period.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Contract Research Oganization Market Projections 2027 | IQVIA, Pharmaceutical Product Development and PRA Health Science, PAREXEL here
News-ID: 2280679 • Views: …
More Releases from Global Market Insight, Inc
Inhalation Anesthesia Market Projections 2025 | Abbott, Baxter International, Ha …
Global inhalation anesthesia market is poised to gain massive momentum over the forecast period of 2019 to 2025. This can be credited to the significant rise in product adoption primarily driven by increasing surgical procedures related to respiratory, neurological and chronic disorders. Additionally, supportive reimbursement scenario across developed countries and availability of several insurance schemes for quick and affordable surgical procedures will increase the application of inhalational anesthetics, thereby supporting…
Health Insurance Market Trends 2025 | Aetna, Blue Cross Blue Shield Companies, C …
Regular occurrences of long-term diseases will bolster the health insurance industry trends in the next few years. This rise can be attributed to the changing dietary habits, lack of physical activities, poor nutrition, excessive alcohol use, and tobacco consumption.
Various Government-backed initiatives by several programs like State Children's Health Insurance Program, Medicaid, Life programs, Department of Defense, TRICARE are employed to provide health insurance policies. Centers for Medicare & Medicaid…
Ambulance Services Market Outlook 2021-2026 | Acadian Ambulance Service, BVG Ind …
The global ambulance services market is estimated to foresee momentous growth through the forthcoming time period owing to an upsurge in road accidents. Additionally, the growing prevalence of chronic diseases and increasing medical tourism trend is further slated to augment the overall market size through 2026.
Additionally, the introduction of new ambulance models and launch of new technologies that focus on the enhancement of ambulatory care is likely to proliferate…
Biosimilars Market Forecast 2025 | Amgen, Biocon, Biogen, Boehringer Ingelheim, …
Touted to be an intrinsic sub-vertical of healthcare and medical devices industry, biosimilars market is poised to record phenomenal gains in the upcoming years owing to the fact that these play a pivotal role in augmenting public health issue by addressing the customer needs to a much larger extent. Numerous reports suggest that biosimilars would result in overall potential savings of nearly USD 100 billion by the end of 2020,…
More Releases for CRO
Global Veterinary CRO & CDMO Market Size & Trends
According to a new market research report published by Global Market Estimates, the global veterinary CRO & CDMO market is expected to grow at a CAGR of 9.1% from 2023 to 2028.
The growing awareness regarding the importance of animal health and welfare has led to increased investments in veterinary pharmaceutical research and development. This awareness is driven by the rising concern for the well-being of pets, livestock, and animals used…
Global Contract Research Organization (CRO) Services Market
According to a new market research report published by Global Market Estimates, the Global Contract Research Organization (CRO) Services Market is expected to grow at a CAGR of 10.2% from 2023 to 2028.
The growth of the contract research organization (CRO) Services Market is fuelled by factors including the rising preference for outsourcing clinical trials, increasing investments in research and development by pharmaceutical and biopharmaceutical companies, the growing complexities in drug…
Contract Research Organization (CRO) Services Market - Efficiency, Expertise, Ex …
Newark, New Castle, USA: The "Contract Research Organization (CRO) Services Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Contract Research Organization (CRO) Services Market: https://www.growthplusreports.com/report/contract-research-organization-cro-services-market/7630
This latest report…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Pracedo Promote Ellie Copp To CRO
Pracedo, a Mashfrog Group company that provides Salesforce consultancy and digital transformation to charities, NGOs, and enterprise customers, promotes Ellie Copp to Chief Revenue Officer.
Pracedo announced Ellie Copp as its new Chief Revenue Officer (CRO). Ellie joined Pracedo in 2019 and most recently held the position of Sales and Marketing Director. As CRO, she will continue to lead the commercial teams by overseeing all revenue-generating activities as Pracedo continues…
Partnership factors in sponsor – CRO relationships
Drugs discovered today can realistically cost upwards of 900 million dollars and around 12 years of development to reach a market. CRO’s have been increasingly used by larger pharma to outsource their clinical research, allowing big pharma to shut down in-house R&D, in practice saving money.
There have been some issues however with the outsourcing of trials to CROs, including serious relationship break down with negative attitudes, failure to communicate…
